Influence of Cimicifuga Racemosa on the Proliferation of Estrogen Receptor-Positive Human Breast Cancer Cells
- 1 November 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 76 (1) , 1-10
- https://doi.org/10.1023/a:1020241509382
Abstract
Hormone replacement therapy, which is a common menopausal treatment, is contraindicated in women with breast cancers due to concerns regarding the potential for breast cell proliferation. As such,...Keywords
This publication has 16 references indexed in Scilit:
- Fukiic and Piscidic Acid Esters from the Rhizome ofCimicifuga racemosaand thein vitroEstrogenic Activity of Fukinolic AcidPlanta Medica, 1999
- In Vitro Test Systems for the Evaluation of the Estrogenic Activity of Natural ProductsPlanta Medica, 1999
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor βEndocrinology, 1998
- Modulation of MCF-7 cell proliferative responses by manipulation of assay conditionsToxicology in Vitro, 1997
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Flavones in Extracts ofCimicifuga racemosaPlanta Medica, 1997
- Cimicifuga and Melbrosia lack oestrogenic effects in mice and ratsMaturitas, 1996
- Untersuchungen zur proliferativen Potenz von Phytopharmaka mit östrogenähnlicher Wirkung bei MammakarzinomzellenArchiv für Gynäkologie, 1993
- Effects of Extracts fromCimicifuga racemosaon Gonadotropin Release in Menopausal Women and Ovariectomized RatsPlanta Medica, 1991
- Untersuchungen zur endokrinen Wirksamkeit von Inhaltsstoffen ausCimicifuga racemosaPlanta Medica, 1985